Teva beat estimates on earnings and revenues for both the quarter and the fiscal year and its outlook for 2017 is better than the consensus estimates.
Paul Ausick 24/7 Wall St. has put together a preview of Cisco, Pepsico and some of the other most anticipated quarterly earnings reports expected this coming week.
Stocks were indicated marginally higher on Friday morning on what seems to be a very light news day. The Dow is still above 20,000 and the S&P 500 has gone above the…
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Gilead Sciences, Gale Biopharma, Teva, and Fitbit post new 52-week lows Wednesday.
Teva, Michael Kors, Sabre, and comScore all posted new 52-week lows Tuesday.
Paul Ausick Teva Pharmaceutical saw its shares tumble on Tuesday after the company announced a changing of the guard. This CEO departure may have been long overdue.
Chris Lange Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) saw its shares make a huge gain on Tuesday after the firm reported a key legal decision in its favor. Essentially, the U.S. District Court for the…
Chris Lange When pharmaceutical companies lose patent cases on the blockbuster drugs, it usually means that they are at risk of losing billions of dollars in drug sales.
Jon C. Ogg The top analyst upgrades, downgrades and initiations seen on Tuesday include BP, Fitbit, Randgold Resources, SLM, Teva Pharmaceuticals, T-Mobile and GoPro.
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
DryShips, Teva, Endo Pharma, and Gilead Sciences posted new 52-week lows Monday.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.
Macy's, Teva, DryShips, Merrimack Pharma lead Wednesday's 52-week low club.
2016 was hard for biotech stocks, some more than others. These three present a buy low opportunity.
